Atherosclerosis is a chronic disease of medium and large arteries characterized by lipid accumulation, inflammation, fibrous tissue formation, and development of atherosclerotic plaques within the arterial wall. Plaques can progressively narrow arteries or rupture and trigger acute thrombosis.
Atherosclerosis is a chronic disease of the arterial wall characterized by accumulation of lipids, inflammatory cells, connective tissue, and cellular debris within the tunica intima. These changes produce raised lesions called atherosclerotic plaques, or atheromas, that can progressively alter the structure and function of affected arteries.
Atherosclerosis primarily affects large elastic arteries and medium-sized muscular arteries. Important sites include the aorta, coronary arteries, carotid arteries, cerebral arteries, renal arteries, and arteries supplying the lower limbs.
The clinical consequences depend not only on the degree of arterial narrowing but also on plaque composition and stability. A plaque may gradually restrict blood flow, weaken the arterial wall, or suddenly rupture or erode, exposing thrombogenic material and producing an acute arterial thrombus.
Understanding atherosclerosis requires knowledge of the normal arterial wall. Arteries are organized into three major layers: the tunica intima, tunica media, and tunica adventitia.
| Arterial Layer | Major Components | Relevance to Atherosclerosis |
|---|---|---|
| Tunica intima | Endothelium and subendothelial connective tissue | Primary site of plaque development |
| Tunica media | Smooth muscle cells and extracellular matrix | Smooth muscle cells can migrate into the intima and contribute to plaque formation |
| Tunica adventitia | Connective tissue, nerves and small vessels | Provides structural support and participates in vascular inflammatory responses |
The tunica intima is the innermost layer of an artery and is directly exposed to circulating blood.
Atherosclerotic lesions develop predominantly within this layer, where lipoproteins, inflammatory cells, smooth muscle cells, and extracellular matrix accumulate.
The endothelium forms the cellular lining of the arterial lumen. It regulates vascular tone, permeability, thrombosis, inflammation, and interactions between circulating blood cells and the vessel wall.
Altered endothelial function is an important early feature in the development of atherosclerosis.
Endothelial dysfunction describes impairment of normal endothelial regulatory functions. It can promote increased permeability to lipoproteins, leukocyte adhesion, inflammatory signaling, vasomotor abnormalities, and a prothrombotic environment.
These changes create conditions that favor the initiation and progression of atherosclerotic lesions.
Atherosclerosis develops through a complex interaction among circulating lipoproteins, the arterial wall, inflammatory cells, vascular smooth muscle cells, and extracellular matrix.
Retention of cholesterol-rich apolipoprotein B-containing lipoproteins within the arterial intima is a central event in plaque formation.
Low-density lipoprotein and related atherogenic particles can enter and become retained within the intima.
Once retained, these lipoproteins can undergo modifications that promote local inflammatory responses and recruitment of circulating immune cells.
Activated endothelial cells express molecules that facilitate adhesion and migration of circulating leukocytes.
Monocytes enter the intima and differentiate into macrophages, becoming major cellular participants in early atherosclerotic lesions.
Macrophages take up modified lipoprotein particles through several receptor pathways.
Progressive intracellular accumulation of lipid gives these cells a characteristic foamy appearance.
Foam cells are lipid-laden macrophages and, in some lesions, lipid-containing smooth muscle cells.
The accumulation of foam cells within the arterial intima is a characteristic feature of early atherosclerosis.
The fatty streak is an early visible lesion of atherosclerosis composed largely of lipid-filled cells within the intima.
Fatty streaks can occur relatively early in life and do not necessarily produce significant obstruction of arterial blood flow.
Some early lesions progress as lipid accumulation and inflammation continue.
Smooth muscle cell migration, proliferation, extracellular matrix deposition, and development of a lipid-rich necrotic core transform the lesion into a more complex atherosclerotic plaque.
Vascular smooth muscle cells normally occupy the tunica media.
During atherogenesis, smooth muscle cells can migrate into the intima, proliferate, produce extracellular matrix, and contribute to formation of the plaque's fibrous component.
Smooth muscle cells produce collagen and other extracellular matrix components within developing plaques.
This matrix contributes to the structure of the fibrous cap that separates the thrombogenic plaque interior from circulating blood.
An established atherosclerotic plaque typically contains a fibrous cap overlying a lipid-rich and necrotic core.
The plaque may also contain inflammatory cells, smooth muscle cells, extracellular lipid, cholesterol crystals, calcification, and areas of hemorrhage.
| Component | Characteristics |
|---|---|
| Fibrous cap | Collagen-rich tissue containing smooth muscle cells |
| Necrotic lipid core | Extracellular lipid, cholesterol and cellular debris |
| Inflammatory cells | Macrophages, T lymphocytes and other immune cells |
| Smooth muscle cells | Contribute to matrix formation and plaque structure |
| Calcification | May develop within advanced lesions |
The fibrous cap forms the surface of many mature plaques and separates the circulating blood from the plaque's deeper lipid-rich material.
Its structural integrity is important because disruption of the cap can expose highly thrombogenic plaque components to blood.
Advanced plaques often contain a necrotic core composed of extracellular lipid, cholesterol, dead cells, and cellular debris.
Expansion of this core can contribute to plaque growth and influence plaque stability.
Atherosclerosis is a chronic inflammatory process as well as a lipid-storage disorder.
Macrophages, lymphocytes, inflammatory mediators, and interactions among vascular cells contribute to lesion progression and can influence fibrous cap integrity.
As a plaque enlarges, the arterial wall can undergo structural remodeling.
Early outward expansion of the vessel may partially preserve lumen size despite increasing plaque burden. With further progression, plaque growth can increasingly encroach on the lumen.
Stenosis is narrowing of the vascular lumen.
Progressive atherosclerotic stenosis can limit the ability of an artery to increase blood flow when tissue metabolic demand rises.
The functional effect of a stenosis depends on its severity, length, vascular territory, collateral circulation, and downstream tissue requirements.
Severe narrowing can produce tissue ischemia, particularly when oxygen demand increases.
Some plaques have relatively thick fibrous caps, smaller lipid cores, and less active inflammation.
Such lesions may remain structurally intact while gradually narrowing the arterial lumen and producing chronic ischemic symptoms.
Other plaques may have a relatively thin fibrous cap, a substantial lipid-rich core, and prominent inflammatory activity.
These structural characteristics can increase susceptibility to plaque disruption and acute thrombosis.
Plaque rupture occurs when the fibrous cap is disrupted and the thrombogenic contents of the plaque become exposed to circulating blood.
Platelet activation and coagulation can then rapidly produce a thrombus at the site of disruption.
Acute arterial thrombosis can also develop over areas of superficial endothelial injury without classic rupture of the fibrous cap.
This mechanism is commonly termed plaque erosion.
A thrombus forming on a disrupted atherosclerotic plaque can partially or completely obstruct the arterial lumen.
This transition from chronic plaque disease to acute thrombosis is responsible for many major cardiovascular emergencies.
| Process | Potential Consequence |
|---|---|
| Progressive plaque enlargement | Chronic arterial stenosis and reduced flow reserve |
| Plaque rupture or erosion | Acute thrombosis |
| Complete thrombotic occlusion | Acute tissue ischemia and infarction |
| Weakening of arterial wall | Aneurysmal dilation in susceptible vessels |
Atherosclerosis does not affect all arteries equally. Lesions preferentially develop at particular anatomical locations, especially regions where blood flow patterns create disturbed shear stress.
Branch points, bifurcations, and curved arterial segments are commonly affected.
Atherosclerosis of the coronary arteries can restrict myocardial blood flow.
Chronic flow limitation may contribute to myocardial ischemia during increased demand, while acute plaque disruption and thrombosis can produce an acute coronary syndrome or myocardial infarction.
Atherosclerotic plaques frequently develop near the carotid bifurcation and proximal internal carotid artery.
These lesions can reduce cerebral perfusion or serve as a source of embolic material that travels into intracranial arteries.
Atherosclerosis can involve arteries supplying the brain.
Thrombotic occlusion, embolization from proximal plaques, or disease of intracranial vessels can contribute to ischemic stroke.
The aorta is a common site of advanced atherosclerosis.
Aortic plaques can become calcified, ulcerated, or complicated by superimposed thrombosis, and atherosclerotic degeneration can contribute to weakening of the arterial wall.
Atherosclerotic narrowing of the renal arteries can reduce renal perfusion.
In selected cases, this can contribute to renovascular hypertension and impaired renal function.
Atherosclerosis involving arteries of the lower limbs is a major cause of peripheral arterial disease.
Commonly affected territories include the aortoiliac, femoropopliteal, and infrapopliteal arterial systems.
Atherosclerosis develops through interactions among genetic, metabolic, behavioral, and environmental factors.
Major established risk factors include elevated atherogenic lipoproteins, hypertension, cigarette smoking, diabetes mellitus, increasing age, and family or genetic predisposition.
Elevated concentrations of atherogenic lipoproteins increase the likelihood that cholesterol-containing particles will enter and remain within the arterial wall.
Long-term exposure to elevated LDL cholesterol is strongly associated with development and progression of atherosclerotic cardiovascular disease.
Elevated arterial pressure contributes to vascular injury and promotes atherosclerotic disease.
Hypertension also increases the overall cardiovascular consequences of established arterial disease.
Cigarette smoking adversely affects endothelial function, inflammation, thrombosis, and other vascular processes.
It is a major modifiable risk factor for coronary, cerebrovascular, and peripheral arterial disease.
Diabetes substantially increases the risk of atherosclerotic cardiovascular disease.
Metabolic abnormalities associated with diabetes can promote endothelial dysfunction, inflammation, altered lipoprotein metabolism, and vascular injury.
Atherosclerosis itself can remain clinically silent for many years.
Symptoms usually develop when plaques significantly limit blood flow or when an acute plaque complication causes thrombosis or embolization.
Atherosclerotic disease of the coronary arteries can cause chronic coronary syndromes and acute coronary syndromes.
The clinical presentation depends on plaque anatomy, degree of obstruction, myocardial oxygen demand, collateral circulation, and whether acute thrombosis has occurred.
Many myocardial infarctions result from acute disruption of a coronary atherosclerotic plaque followed by thrombus formation.
Severe reduction or interruption of coronary blood flow can cause irreversible injury to myocardial tissue.
Atherosclerosis can contribute to ischemic stroke through local arterial thrombosis or embolization from atherosclerotic lesions in larger arteries.
Carotid and aortic plaques can be clinically important sources of embolic material.
Atherosclerotic obstruction of limb arteries can reduce blood flow to skeletal muscle and other tissues.
Exertional ischemic discomfort, impaired wound healing, and severe limb ischemia can occur as disease progresses.
Intermittent claudication is exertional muscle discomfort caused by inadequate arterial blood flow relative to metabolic demand.
Symptoms typically improve with rest as tissue oxygen requirements decrease.
Advanced atherosclerotic disease can coexist with degenerative changes that weaken the arterial wall, particularly in the abdominal aorta.
Loss of structural integrity can contribute to progressive arterial dilation and aneurysm formation.
Material associated with an atherosclerotic plaque or overlying thrombus can detach and travel distally through the arterial circulation.
Such emboli may obstruct smaller vessels and cause downstream ischemia.
Advanced plaques frequently undergo calcification.
Vascular calcification contributes to arterial stiffness and can be detected using several imaging techniques.
Atherosclerosis may be evaluated indirectly through its effects on blood flow or directly through imaging of the arterial wall and lumen.
The approach depends on the vascular territory and clinical question.
Vascular ultrasonography can assess arterial anatomy and blood flow.
Doppler techniques can identify altered flow patterns associated with stenosis, while carotid ultrasound can demonstrate plaque and measure structural features of the vessel.
Computed tomography can demonstrate vascular calcification and, when combined with angiographic techniques, provide detailed assessment of arterial lumen and wall anatomy.
Coronary artery calcium detected by CT reflects calcified coronary atherosclerotic plaque burden.
Calcium scoring can be used in selected clinical settings as part of cardiovascular risk assessment.
CT angiography can visualize arterial lumens and vessel walls after administration of contrast material.
It can demonstrate stenosis, occlusion, plaque, aneurysmal changes, and other vascular abnormalities.
Catheter-based angiography outlines the arterial lumen using contrast material and radiographic imaging.
It provides detailed anatomical information and can be combined with interventional procedures when appropriate.
Management of atherosclerotic disease focuses on reducing cardiovascular risk, slowing plaque progression, preventing thrombotic complications, and restoring blood flow when clinically necessary.
Approaches vary according to the affected vascular territory and severity of disease.
Reducing circulating concentrations of atherogenic lipoproteins can slow progression of atherosclerotic disease and reduce the risk of cardiovascular events.
Therapeutic strategies may include lifestyle measures and lipid-lowering medications.
Control of elevated blood pressure reduces mechanical stress on the cardiovascular system and lowers the risk of complications associated with atherosclerotic disease.
Stopping cigarette smoking reduces ongoing vascular injury and substantially lowers cardiovascular risk over time.
Platelets play a central role in arterial thrombosis after plaque disruption.
Antiplatelet medications are therefore used in selected patients with established atherosclerotic cardiovascular disease or specific acute vascular conditions.
In selected arterial lesions, a catheter-mounted balloon can be used to enlarge a narrowed lumen.
A vascular stent may then be placed to help maintain vessel patency.
When arterial disease is extensive or anatomically unsuitable for catheter-based intervention, blood flow may be redirected around obstructed segments using a surgical graft.
Coronary artery bypass grafting is an important example.
| Arterial Territory | Potential Consequence |
|---|---|
| Coronary arteries | Myocardial ischemia and myocardial infarction |
| Carotid and cerebral arteries | Transient ischemic attack and ischemic stroke |
| Aorta | Aneurysmal disease, embolization and other aortic complications |
| Renal arteries | Renal ischemia and renovascular hypertension |
| Lower limb arteries | Peripheral arterial disease and limb ischemia |
| Stage | Major Change |
|---|---|
| Endothelial dysfunction | Altered endothelial permeability and inflammatory signaling |
| Lipoprotein retention | Atherogenic particles accumulate within the intima |
| Foam cell formation | Macrophages accumulate lipid |
| Fatty streak | Early visible intimal lesion develops |
| Fibrous plaque | Smooth muscle cells and extracellular matrix form a fibrous cap around a lipid-rich core |
| Advanced plaque | Lesion may enlarge, calcify, hemorrhage or weaken the arterial wall |
| Plaque disruption | Rupture or erosion exposes thrombogenic material |
| Thrombosis | Acute clot formation may partially or completely obstruct blood flow |
| Feature | Key Point |
|---|---|
| Primary site | Tunica intima of medium and large arteries |
| Early lesion | Fatty streak |
| Characteristic advanced lesion | Atherosclerotic plaque |
| Major plaque components | Lipid, inflammatory cells, smooth muscle cells and extracellular matrix |
| Chronic effect | Progressive arterial stenosis and impaired blood flow |
| Major acute complication | Plaque disruption with thrombosis |
| Important territories | Coronary, carotid, cerebral, aortic, renal and peripheral arteries |
| Major clinical outcomes | Myocardial infarction, ischemic stroke and peripheral arterial disease |
Atherosclerosis transforms the normal architecture of the arterial wall. What begins as retention of atherogenic lipoproteins within the intima can develop into a complex lesion containing inflammatory cells, smooth muscle cells, fibrous tissue, lipid, necrotic debris, and calcium.
The anatomical consequences extend beyond simple narrowing of the lumen. Plaques can remodel the vessel wall, alter arterial compliance, compromise branch vessels, weaken underlying arterial structures, and create surfaces capable of triggering thrombosis.
The distinction between chronic stenosis and acute plaque disruption is especially important. A slowly enlarging plaque may progressively limit tissue perfusion, while rupture or erosion of a plaque can abruptly transform previously stable arterial disease into an acute thrombotic emergency such as myocardial infarction or ischemic stroke.